Accenture and Sumitomo Chemical Establish Joint Venture to Drive Digital Transformation
TOKYO, Mar. 1, 2021 – Accenture (NYSE: ACN) and Sumitomo Chemical have established a joint venture SUMIKA DX ACCENT, which began operations today. The joint venture will leverage the power of artificial intelligence (AI), data analytics and other technologies to transform operations and create new businesses at Sumitomo Chemical Group. It is 80% owned by Sumitomo Chemical and 20% by Accenture.